Skip to main content
Clinical Trials/NCT01654055
NCT01654055
Completed
Not Applicable

International Multicentre Prospective Study on Morphine-induced Adverse Drug Reactions in Emergency Departments: Description and Predictive Factors.

University Hospital, Toulouse1 site in 1 country1,128 target enrollmentOctober 2011
ConditionsEmergencies

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Emergencies
Sponsor
University Hospital, Toulouse
Enrollment
1128
Locations
1
Primary Endpoint
Occurrence of morphine related adverse-event
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

Morphine is the gold standard for treatment of severe acute pain but it has a number of adverse effects.

No study has so far managed to identify the morphine-induced adverse drug reactions. The primary objective of this study is to determine predictive factors of morphine-induced adverse drug reaction when it is used in emergency departments.

Detailed Description

We want to study a large cohort of morphine-induced adverse drug reactions patients, the consequences for patients, mainly in terms of severity, and predictive criteria. This will allow us to identify some patients most at risk of morphine-induced adverse drug reactions, and thus to adapt morphine titration and monitoring of these patients. Leading to a better understanding and a better prediction of adverse effects in patients, it is possible that part of the "opiophobia" which persists in emergency services disappear. Finally, it is toward a better security but also a better efficiency in the management of pain patients in emergencies that leads this study. The secondary objectives are: To determine the frequency and severity of adverse events related to morphine. To establish an inventory of morphine use in emergency departments in the different centres studied.

Registry
clinicaltrials.gov
Start Date
October 2011
End Date
August 2012
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • All patients aged 18 years or older who require treatment with morphine for pain control will be considered for entry into the study.
  • Conscious without life threatening at the inclusion

Exclusion Criteria

  • Patients who receive morphine during or after an orotracheal intubation, altered level of consciousness, inability to give consent or refusal of patient.

Outcomes

Primary Outcomes

Occurrence of morphine related adverse-event

Time Frame: From the administration of morphine until 6 hours after this first administration

The primary outcome variable will be defined as occurrence of morphine related adverse-event (including nausea, dizziness, emesis, drowsiness, pruritus, respiratory distress and death)

Secondary Outcomes

  • Description of adverse effects caused by morphine(For each side effects of morphine from the first administration of morphine until 6 hours after.)

Study Sites (1)

Loading locations...

Similar Trials